What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His main research concerns Internal medicine, Endocrinology, Insulin, Insulin receptor and Insulin resistance.
His study in Insulin oscillation, Islet, Glucose homeostasis, IRS2 and Pancreatic islets is carried out as part of his Internal medicine studies.
His studies in Endocrinology integrate themes in fields like Receptor, Protein kinase B and Cell biology.
His research in the fields of Beta cell overlaps with other disciplines such as Calcium metabolism.
His study in Insulin receptor is interdisciplinary in nature, drawing from both Knockout mouse and Hyperinsulinemia.
In his research, TRIB3, Incretin and Diabetes mellitus genetics is intimately related to Glucose uptake, which falls under the overarching field of Insulin resistance.
His most cited work include:
- Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction (1050 citations)
- Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes (998 citations)
- New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure (843 citations)
What are the main themes of his work throughout his whole career to date?
Rohit N. Kulkarni focuses on Internal medicine, Endocrinology, Insulin, Insulin resistance and Cell biology.
All of his Endocrinology and Insulin receptor, Glucose homeostasis, Islet, Diabetes mellitus and Insulin oscillation investigations are sub-components of the entire Endocrinology study.
His work carried out in the field of Insulin receptor brings together such families of science as PI3K/AKT/mTOR pathway, Downregulation and upregulation and Glucagon secretion.
The various areas that Rohit N. Kulkarni examines in his Insulin study include Adipose tissue, Protein kinase B, Knockout mouse and Carbohydrate metabolism.
The study incorporates disciplines such as Epigenetics and Type 2 diabetes in addition to Insulin resistance.
His Cell biology research incorporates themes from Cell, Receptor and Induced pluripotent stem cell.
He most often published in these fields:
- Internal medicine (63.73%)
- Endocrinology (60.46%)
- Insulin (44.44%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (29.08%)
- Insulin resistance (32.68%)
- Internal medicine (63.73%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cell biology, Insulin resistance, Internal medicine, Endocrinology and Insulin.
His Cell biology research is multidisciplinary, incorporating elements of Cell, Proteomics, Induced pluripotent stem cell, Translation and Islet.
He interconnects Gene expression, FOXO1, Gene silencing, Epigenetics and Type 2 diabetes in the investigation of issues within Insulin resistance.
His Insulin receptor, Steatosis and Thiamine study in the realm of Internal medicine interacts with subjects such as Nonalcoholic fatty liver disease.
His work in the fields of Diabetes mellitus genetics overlaps with other areas such as Solute carrier family.
He has included themes like Diabetes mellitus, Messenger RNA, Transdifferentiation and Pharmacology in his Insulin study.
Between 2018 and 2021, his most popular works were:
- m 6 A mRNA Methylation Regulates Human β-Cell Biology in Physiological States and in Type 2 Diabetes (42 citations)
- RADAR: differential analysis of MeRIP-seq data with a random effect model (34 citations)
- β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity (31 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His scientific interests lie mostly in Insulin resistance, Islet, Internal medicine, Endocrinology and Cell.
His Insulin resistance study results in a more complete grasp of Insulin.
He has researched Islet in several fields, including Inflammation, Secretion, Cancer research and Cytokine.
His study in the field of Steatosis, Metabolic syndrome and Insulin receptor also crosses realms of Nonalcoholic fatty liver disease.
His Endocrinology research incorporates elements of Downregulation and upregulation and Epigenetics.
Rohit N. Kulkarni combines subjects such as MAPK/ERK pathway, Cell growth, Pancreas and Cell biology with his study of Cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
